Use of spiro-oxindole compounds as therapeutic agents

Details for Australian Patent Application No. 2007319580 (hide)

Owner Xenon Pharmaceuticals Inc.

Inventors Hou, Duanjie; Seid Bagherzadeh, Mehran; Sviridov, Serguei; Fu, Jianmin; Kamboj, Rajender; Sun, Jianyu; Chakka, Nagasree; Sun, Shaoyi; Chowdhury, Sultan; Raina, Vandna; Liu, Shifeng; Chafeev, Mikhail; Hsieh, Tom; Fraser, Robert

Agent Davies Collison Cave

Pub. Number AU-A-2007319580

PCT Pub. Number WO2008/060789

Priority 60/851,787 12.10.06 US

Filing date 12 October 2007

Wipo publication date 22 May 2008

International Classifications

A61K 31/437 (2006.01)

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 13/08 (2006.01) Drugs for disorders of the urinary system

A61P 17/04 (2006.01) Drugs for dermatological disorders

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

23 April 2009 PCT application entered the National Phase

  PCT publication WO2008/060789 Priority application(s): WO2008/060789

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007319586-Antimicrobial articles and method of manufacture

2007319578-Methods for treatment of cochlear and vestibular disorders